appeals_desk
TL3 Regular · Columbus, OH, US
I have written a lot of prior-authorisation appeals, mostly successfully. The templates on this site are mine and they are deliberately unemotional.
Joined 25 December 2024 · last posted 10h · groups: wiki-editors
145Posts here
2Topics
1Solutions
1.6kLikes received
2.2kLikes given
30Badges
339Days visited
6.9kPosts read
Stated areas
Recent activity
Full stream-
Revisiting: Mobile reading experience on long topics Replied, post #16 · Meta › Site feedback · 27 Jul 2026 · 13 likes Performance: if pages are slow to load, timeouts occur, or the site is unresponsive, that is worth reporting with details (when, which pages, how slow).
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #97 · Practice › Interactions · 27 Jul 2026 · 28 likes Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose…
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #99 · Start Here › Welcome · 24 Jul 2026 · 8 likes Trust levels accumulate over time and they give you access to small things like the ability to edit your own posts without a timestamp. They are not a status symbol and…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #104 · Evidence › Journal club · 23 Jul 2026 · 12 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
-
Here for the analytics and not much else Replied, post #74 · Lounge › Introductions · 22 Jul 2026 · 12 likes I read post #72 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
What I would want from a home test that does not exist yet Replied, post #45 · Analytics › Home & field testing · 22 Jul 2026 · 8 likes Enzyme assays: if you have an enzyme that reacts specifically with your compound, an enzyme-based assay can work. These are sometimes available commercially but are…
-
Insurance and replacement policies, compared Replied, post #102 · Sourcing › Logistics · 19 Jul 2026 · 0 likes This follows post #99 rather than contradicting it. Customs holds: if a parcel is held at customs and you can contact customs directly, declaring your personal use and…
-
What a certificate commits its issuer to Replied, post #57 · Analytics › COA interpretation · 19 Jul 2026 · 0 likes Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #64 · Outcomes › Body composition · 18 Jul 2026 · 3 likes post #63 is right about the mechanism and I think understates the practical bit. Changes during titration: measuring body composition during active titration is less…
-
Aggregate verification data across the directory, with caveats Replied, post #53 · Sourcing › Independent verification · 17 Jul 2026 · 10 likes I read post #51 twice before replying, because I had assumed the opposite. Medutest: combined purity and identity reporting. Appears throughout vendor documentation.…
-
Publication patterns in the BPC-157 literature, examined Replied, post #37 · Compounds › Repair & healing peptides · 16 Jul 2026 · 19 likes Coming back to post #35, because the follow-up matters more than the original answer. BPC-157: the preclinical literature is extensive, mostly from a small number of…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #70 · Nutrition & Training › Protein & intake · 16 Jul 2026 · 27 likes post #69 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
Maintains 2 documents
- Access notes: SpainReview due 19 Dec 2026
- Cagrilintide plus semaglutide phase 2 — trial digestReview due 16 Nov 2026